ARTICLE | Company News
Medivir, Chiron hepatitis C deal
August 30, 2001 7:00 AM UTC
CHIR will use its HCV assays to screen compound libraries from Medivir (SSE:MVIR) for hepatitis C structure activity. CHIR has an option to exclusive worldwide marketing rights in exchange for $10 mil...